期刊文献+

质子泵抑制剂研究进展和研究方向 被引量:16

Research Advancement and Direction of Proton Pump Inhibitor
暂未订购
导出
摘要 目的探讨质子泵抑制剂的药理作用和临床应用进展,以及药物本身存在的缺陷和不足,探索其研究方向。方法查阅文献总结质子泵抑制剂的药理作用、临床应用、市场现状、存在缺陷及发展方向。结果质子泵抑制剂在我国消化系统用药市场上居于霸主地位,但存在结构缺陷和应用缺陷。结论有必要对质子泵抑制剂进一步改进,以增加其稳定性、提高生物利用度、提高疗效且降低毒副作用。 Objective To explore the pharmacologic functions of the proton pump inhibitor, research development in clinical application, defect and shortages existing as medicine, and also to explore the research direction of the proton pump inhibitor. Methods To summarize the pharmacology functions of the proton pump inhibitor, clinical application, market present condition, existent blemish and the development directions by reviewing literature, Results The proton pump inhibitor has the main position on the market of digest drugs in our country, but exist the structure defect and the applied defect. Conclusion It is necessary to improve the proton pump inhibitor further, for increasing the stability, raising the therapeutic effect, raising the bioavailability and lowering the poisonous side effect.
出处 《中国药业》 CAS 2008年第2期23-24,共2页 China Pharmaceuticals
关键词 质子泵抑制剂 药理作用 进展 proton pump inhibitor development pharmacologic function
  • 相关文献

参考文献14

  • 1Besancon M,Simon A,Sachsg,et al. Sites of reaction of the gastric H^+, K^+ -ATPase with extracytoplasmic thiol reagents[J]. Journal of Biological Chemistry, 1997, 272:22 438 - 22 446.
  • 2Lerang F, Mourn B, Hang JB, et al. Highly effective twice a day triple therapies for Helicobacter pylori infection and peptic ulcer disase: metronidazole resistance is of only minor importance [J]. Gastroenterology, 1996, 110: A173.
  • 3Welage LS, Berardi RR. Evaluation of Omeprazole. Lansopra - zole, Pantoprazole, in the treatment of acid related disease [ J ]. Jam Pharm Assoe Wash, 2000,40(1): 56 -62,121 - 123.
  • 4Mauch F, Bode G. Identification and characterization of an ATP ase system of Helicobacter pylori and the effect of proton pump inhibitors[J]. Am J Gastroenteml, 1993,88(10) : 1 801 - 1 802.
  • 5Varia D, A li A, GattaL, et al. Treatment of Helicobacter pylori[J]. Current Opinion Gastroenterology, 1998,14 Suppl 1 : 71S - 78S.
  • 6Smout AJ. Is the sensitivity to gastric acid inhibition Helicobacter pylori status dependent [ J ]. Scand J Gastroenterol, 1998,225 (Suppl) : 32.
  • 7Casbarrini A, Ojetti V, Pitocco D, et al. Efficacy of diferent Helicobacter pylori eradication regimens in patients affected by insul independent diabetes mellitus[ J]. Scand J Gastroenterol,2000, 35 (3) : 260 - 263.
  • 8Caro JJ. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton- pump inhibitors lansoprazole, raboprazole and pantoprazole compared with omeprazole ranitidine and placebo: eviderce from randomized clinical trials[J]. Clin Ther, 2001,23: 998.
  • 9Johnson DA, Benjamin SB. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophagcal reflux disease symptoms: a randomized double blind,placebo controlled study of efficacy and safety[J] . Am J Gastroenterol, 2001,96:27 - 34.
  • 10Berstad A. Atacids and pepsin[J] .Seand J Gastroenterol, 1982, 75 (Suppl) : 13 - 15.

共引文献1

同被引文献85

引证文献16

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部